These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8732390)

  • 21. Successful Tissue Plasminogen Activator for a Patient with Stroke After Stanford Type A Aortic Dissection Treatment.
    Matsuzono K; Suzuki M; Arai N; Kim Y; Ozawa T; Mashiko T; Shimazaki H; Koide R; Fujimoto S
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e132-e134. PubMed ID: 29525082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis with tissue plasminogen activator: protocol violation is not an option.
    Kumar S
    Neurol India; 2007; 55(2):174; author reply 174-5. PubMed ID: 17558129
    [No Abstract]   [Full Text] [Related]  

  • 23. Stroke: Measuring disease-free life after thrombolysis.
    Fagan SC
    Nat Rev Neurol; 2010 Jul; 6(7):361-2. PubMed ID: 20639913
    [No Abstract]   [Full Text] [Related]  

  • 24. Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".
    Manfredini R; Boari B; Gallerani M; Portaluppi F; Mehta RH
    J Vasc Surg; 2003 Aug; 38(2):411-2. PubMed ID: 12894792
    [No Abstract]   [Full Text] [Related]  

  • 25. Is intravenous thrombolysis feasible in a developing country?
    Pandian JD; Sethi V; Dhillon R; Kaur R; Padala S; Chakravorty R; Singh Y
    Cerebrovasc Dis; 2005; 20(2):134-6. PubMed ID: 16006762
    [No Abstract]   [Full Text] [Related]  

  • 26. Repeated doses of tissue plasminogen activator for failed thrombolysis: case report and review of the literature.
    Dakik HA; Nasrallah A
    Heart Dis; 2001; 3(6):362-4. PubMed ID: 11975820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraarterial subclavian artery thrombolysis in a neonate.
    Neff KW; Dinter D; Schaible T; Lehmann KJ; Düber C
    AJR Am J Roentgenol; 2001 Aug; 177(2):446-8. PubMed ID: 11461880
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolytic therapy for myocardial infarction.
    Frei S
    N Engl J Med; 1998 Feb; 338(8):545; author reply 546-7. PubMed ID: 9471556
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
    J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carotid Ultrasonography Can Identify Stroke Patients Ineligible for Intravenous Thrombolysis Therapy due to Acute Aortic Dissection.
    Hama Y; Koga M; Tokunaga K; Takizawa H; Miyashita K; Iba Y; Toyoda K
    J Neuroimaging; 2015; 25(4):671-3. PubMed ID: 25511609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
    Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptokinase versus alteplase in acute myocardial infarction.
    Friedman HS
    J R Soc Med; 1996 Aug; 89(8):427-30. PubMed ID: 8795494
    [No Abstract]   [Full Text] [Related]  

  • 35. New plasminogen activators: a clinical review.
    Ross AM
    Clin Cardiol; 1999 Mar; 22(3):165-71. PubMed ID: 10084057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report: a very large dissection in the left anterior descending coronary artery of a 56-year-old man.
    Capuano C; Sesana M; Predolini S; Leonzi O; Cuccia C
    Cardiovasc Revasc Med; 2006; 7(4):240-2. PubMed ID: 17174872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
    Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
    Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: venous sinus thrombosis: the use of thrombolysis.
    Renowden SA; Oxbury J; Molyneux AJ
    Clin Radiol; 1997 May; 52(5):396-9. PubMed ID: 9171798
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of submacular hemorrhage associated with retinal arterial macroaneurysms.
    Humayun M; Lewis H; Flynn HW; Sternberg P; Blumenkranz MS
    Am J Ophthalmol; 1998 Sep; 126(3):358-61. PubMed ID: 9744368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis for acute stroke: a new era in treatment.
    Gress DR; Bonovich D
    Am Fam Physician; 1997 Jun; 55(8):2590-1. PubMed ID: 9191443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.